Category stocks

Argenx Acquires Forte Biosciences

Argenx buys Forte Biosciences for $77 per share Argenx SE is acquiring Forte Biosciences for $77 per share in cash, valuing the deal at $2.2B. The acquisition adds Forte's lead program to argenx's portfolio. The deal expands argenx's immunology offerings wi

Big Tech Earnings Take Center Stage

Four major tech firms report earnings this week Major tech companies will release their earnings reports this week, with four of the 'Magnificent Seven' set to report. The earnings reports come after Alphabet's setback last week, which raised questions about the co

CXMT Shares Surge In Shanghai Debut

CXMT shares rose over 500% in Shanghai debut CXMT, China's leading memory chipmaker, saw its shares surge more than 500% in their Shanghai market debut. The company raised 57.92B yuan by selling shares at 8.66 yuan apiece, which is equivalent to $8.6B. This stron